CT software start-up Medic Vision raises $1m
The company's product reduces the amount of radiation required in CT scans, lowering the cancer risk.
The company has provided research data showing that 1.5-2% of incidences of cancer in the US are likely to be attributable to CT radiation. The risk among children is much higher.
Medic Vision's product is undergoing trials at the Rambam Hospital in Haifa. The trials have shown that it does indeed reduce the radiation level substantially without affecting the accuracy of the image.
Published by Globes [online], Israel business news - www.globes-online.com - on December 16, 2009
© Copyright of Globes Publisher Itonut (1983) Ltd. 2009
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options